key: cord-0688333-adm2cbge
authors: Wilson, Hunter; Norris, Mark D.; Frosch, Olivia; Agarwal, Prachi P.
title: Late Gadolinium Enhancement After COVID-19 Vaccination
date: 2021-09-30
journal: Radiol Cardiothorac Imaging
DOI: 10.1148/ryct.2021210199
sha: 6a008aaf7662a2a0c647c177b2a28cd57913e09e
doc_id: 688333
cord_uid: adm2cbge

nan

I n p r e s s term implications are unclear, the extensive LGE in this case seen well past resolution of acute symptoms raises concern for ventricular arrhythmia, future diastolic dysfunction, and other sequelae. Further evaluation of patients after symptomatic recovery should be considered given unknown natural history. 

Symptomatic acute myocarditis in seven adolescents following Pfizer-BioNTech COVID-19 vaccination. Pediatrics 2021:2. Online ahead of print

Myocarditis Temporally Associated with COVID-19 Vaccination. Circulation 2021. Online ahead of print

Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases

Clinical Study Agreement MYK-461-005: A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy MyoKardia, Inc.-18-PAF06025 Co-I with Effort (Principal Investigator: Sara Saberi) 06/2018-03/2022. SPIROMICS II Heart Failure Substudy SubK-NIH-DHHS-US through a consortium with Columbia University-19-PAF02625 Co-I with Effort (Principal Investigator: Meilan K Han) 06/2023; editor-in-chief for Seminars in Roentgenology